Clinical Trial

Graves' Disease Remission Study: MycoMeth Combo

Study acronym: 3M-RGD
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated February 28, 2024 (before its estimated October 8, 2025 completion). Its status may not reflect the trial's current state.
Summary
A randomized study to evaluate the efficacy and safety of combining mycophenolate mofetil with methimazole in patients with newly diagnosed Graves' disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-28.
Status change: Not Yet Recruiting → Recruiting 2024-02-27
Trial Details
NCT Number NCT06068179
Lead Sponsor The First Affiliated Hospital of Xiamen University
Conditions Graves' Disease
Enrollment 205 participants
Start Date 2023-10-16
Primary Completion 2025-10-08 (estimated)
Study Completion 2026-10-08 (estimated)
Updated on ClinicalTrials.gov 2024-02-28